Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter L Selby

Showing results (31-40 of 34) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 34 results.
The Journal of Clinical Endocrinology and Metabolism|April 9, 2014
Mutational analysis of the adaptor protein 2 sigma subunit (AP2S1) gene: search for autosomal dominant hypocalcemia type 3 (ADH3)Angela Rogers, M Andrew Nesbit, Fadil M Hannan, et al.
Annals of the Rheumatic Diseases|December 20, 2023
Randomised trial of genetic testing and targeted intervention to prevent the development and progression of Paget's disease of boneJonathan Phillips, Deepak Subedi, Steff C Lewis, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|March 17, 2020
Characteristics of Early Paget's Disease in SQSTM1 Mutation Carriers: Baseline Analysis of the ZiPP Study CohortOwen Cronin, Deepak Subedi, Laura Forsyth, et al.
BMJ Open|September 7, 2019
Zoledronate in the prevention of Paget's (ZiPP): protocol for a randomised trial of genetic testing and targeted zoledronic acid therapy to prevent <i>SQSTM1</i>-mediated Paget's disease of boneOwen Cronin, Laura Forsyth, Kirsteen Goodman, et al.
Pageof 4

Showing results (31-40 of 34) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 34 results.
The Journal of Clinical Endocrinology and Metabolism|April 9, 2014
Mutational analysis of the adaptor protein 2 sigma subunit (AP2S1) gene: search for autosomal dominant hypocalcemia type 3 (ADH3)Angela Rogers, M Andrew Nesbit, Fadil M Hannan, et al.
Annals of the Rheumatic Diseases|December 20, 2023
Randomised trial of genetic testing and targeted intervention to prevent the development and progression of Paget's disease of boneJonathan Phillips, Deepak Subedi, Steff C Lewis, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|March 17, 2020
Characteristics of Early Paget's Disease in SQSTM1 Mutation Carriers: Baseline Analysis of the ZiPP Study CohortOwen Cronin, Deepak Subedi, Laura Forsyth, et al.
BMJ Open|September 7, 2019
Zoledronate in the prevention of Paget's (ZiPP): protocol for a randomised trial of genetic testing and targeted zoledronic acid therapy to prevent <i>SQSTM1</i>-mediated Paget's disease of boneOwen Cronin, Laura Forsyth, Kirsteen Goodman, et al.
Pageof 4